Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


14.06.2021

2 AJR Am J Roentgenol
2 Am J Gastroenterol
1 Anticancer Res
2 Biochem Biophys Res Commun
3 BMC Cancer
3 BMC Gastroenterol
1 Dig Dis
2 Dig Dis Sci
1 Endoscopy
1 Gastroenterology
10 Gastrointest Endosc
1 Gut
14 Hepatology
1 J Gastroenterol
4 J Gastroenterol Hepatol
3 J Hepatol
5 N Engl J Med
3 Oncogene
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology
1 Transplant Proc
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. ARAKI T, Imaizumi A, Okada H, Sasaki Y, et al
    Anatomy of Left Inferior Phrenic Vein in Patients Without Portal Hypertension.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23106.
    PubMed         Abstract available

  2. CHU HH, Kim JH, Shin YM, Won HJ, et al
    Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23461.
    PubMed         Abstract available


    Am J Gastroenterol

  3. LOUISSAINT J, May FP, Williams S, Tapper EB, et al
    Effective Mentorship as a Means to Recruit, Retain, and Promote Underrepresented Minorities in Academic Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:1110-1113.
    PubMed        

  4. HERNANDEZ-CONDE M, Llop E, Gomez-Pimpollo L, Fernandez Carrillo C, et al
    Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 May 26. pii: 00000434-900000000-98756.
    PubMed         Abstract available


    Anticancer Res

  5. AU KY, Chan KK, Lo RC
    A Clinicopathological Study of Young-onset Hepatocellular Carcinoma.
    Anticancer Res. 2021;41:2933-2944.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  6. KIM H, Lee JY, Park SJ, Kwag E, et al
    ZNF746/PARIS promotes the occurrence of hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;563:98-104.
    PubMed         Abstract available

  7. SATO T, Tsuchiya A, Owaki T, Kumagai M, et al
    Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;566:36-44.
    PubMed         Abstract available


    BMC Cancer

  8. YAMAMOTO M, Kobayashi T, Hashimoto M, Kuroda S, et al
    Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification.
    BMC Cancer. 2021;21:668.
    PubMed         Abstract available

  9. XU R, Lin L, Zhang B, Wang J, et al
    Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    BMC Cancer. 2021;21:687.
    PubMed         Abstract available

  10. QU S, Jin L, Huang H, Lin J, et al
    A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
    BMC Cancer. 2021;21:686.
    PubMed         Abstract available


    BMC Gastroenterol

  11. HE Y, Yuan S, Guo X, Yi F, et al
    Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis.
    BMC Gastroenterol. 2021;21:253.
    PubMed         Abstract available

  12. ATALLAH E, Wijayasiri P, Cianci N, Abdullah K, et al
    Zanubrutinib-induced liver injury: a case report and literature review.
    BMC Gastroenterol. 2021;21:244.
    PubMed         Abstract available

  13. FIGUEIRA ERR, Rocha-Filho JA, Lanchotte C, Nacif LS, et al
    Creatinine-lactate score predicts mortality in non-acetaminophen-induced acute liver failure in patients listed for liver transplantation.
    BMC Gastroenterol. 2021;21:252.
    PubMed         Abstract available


    Dig Dis

  14. OP DEN WINKEL M, Nagel D, de la Torre Alaez MA, Hempe S, et al
    A simple prognostic scoring system for hepatocellular carcinoma treated with selective internal radiation therapy.
    Dig Dis. 2021 Jun 10. pii: 000517458. doi: 10.1159/000517458.
    PubMed        


    Dig Dis Sci

  15. PENG X, Tian A, Li J, Mao Y, et al
    Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
    Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
    PubMed         Abstract available

  16. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
    International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
    PubMed         Abstract available


    Endoscopy

  17. MATSUBARA S, Tanaka T, Nakagawa K, Suda K, et al
    Transmural cystoscopy with an ultra-slim basket for migrated stent removal after endosonography-guided hepatic cyst drainage.
    Endoscopy. 2021 May 31. doi: 10.1055/a-1488-6332.
    PubMed        


    Gastroenterology

  18. LI H, Liu H
    Recurrent Epistaxis and Diffuse Hepatic and Splenic Vascular Malformations.
    Gastroenterology. 2021 Jun 8. pii: S0016-5085(21)03091.
    PubMed        


    Gastrointest Endosc

  19. MINAGA K, Kitano M, Nakai A, Omoto S, et al
    Improved liver metastasis detection using Kupffer-phase imaging in contrast-enhanced harmonic EUS in patients with pancreatic cancer (with video).
    Gastrointest Endosc. 2020 Jun 24. pii: S0016-5107(20)34515.
    PubMed         Abstract available

  20. CHEN M, Wang J, Xiao Y, Wu L, et al
    Automated and real-time validation of gastroesophageal varices under esophagogastroduodenoscopy using a deep convolutional neural network: a multicenter retrospective study (with video).
    Gastrointest Endosc. 2021;93:422-432.
    PubMed         Abstract available

  21. MONDAL D, Dey M, Kishalaya, Mitra S, et al
    Spontaneously resolving duodenal obstruction after balloon-occluded retrograde transvenous obliteration-assisted endoscopic Histoacryl injection in duodenal varices.
    Gastrointest Endosc. 2021;93:265-266.
    PubMed        

  22. ROWLEY MW, Suarez J
    Coil migration after EUS-guided coil embolization of gastric varices.
    Gastrointest Endosc. 2021;93:764-765.
    PubMed        

  23. ZHANG W, Lv Y
    Response.
    Gastrointest Endosc. 2021;93:287-288.
    PubMed        

  24. CARRARA S, Repici A
    Kupffer-phase EUS: the contrast agent that magnifies liver metastasis.
    Gastrointest Endosc. 2021;93:442-443.
    PubMed        

  25. BAZARBASHI AN, Ryou M
    Portal pressure measurement: Have we come full circle?
    Gastrointest Endosc. 2021;93:573-576.
    PubMed        

  26. TAMANINI G, Lisotti A, Fusaroli P
    Detection of occult liver metastases during EUS: Does the contrast make the difference?
    Gastrointest Endosc. 2021;93:773.
    PubMed        

  27. MINAGA K, Kitano M
    Response.
    Gastrointest Endosc. 2021;93:773-774.
    PubMed        

  28. STORM AC, Abu Dayyeh BK
    Metabolic function and weight loss after endoscopic sleeve gastroplasty: resistance is futile.
    Gastrointest Endosc. 2021;93:1119-1120.
    PubMed        


    Gut

  29. CHEUNG CCL, Goh D, Lim X, Tien TZ, et al
    Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19.
    Gut. 2021 Jun 2. pii: gutjnl-2021-324280. doi: 10.1136/gutjnl-2021-324280.
    PubMed        


    Hepatology

  30. KOZUMI K, Kodama T, Murai H, Sakane S, et al
    Transcriptomics Identify Thrombospondin-2 as a Biomarker for Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis.
    Hepatology. 2021 Jun 9. doi: 10.1002/hep.31995.
    PubMed         Abstract available

  31. CHO K, Ro SW, Lee HW, Moon H, et al
    YAP/TAZ suppress drug penetration into hepatocellular carcinoma via stromal activation.
    Hepatology. 2021 Jun 8. doi: 10.1002/hep.32000.
    PubMed         Abstract available

  32. CHEN B, Wu JX, Cheng SH, Wang LM, et al
    Phase II study of adjuvant radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma.
    Hepatology. 2021 Jun 7. doi: 10.1002/hep.31993.
    PubMed         Abstract available

  33. JINDAL A, Jagdish RK
    Response to terlipressin plus albumin in Hepatorenal syndrome - Need a closer look!
    Hepatology. 2021 Jun 6. doi: 10.1002/hep.31990.
    PubMed         Abstract available

  34. WONG TC, Lee VH, Law AL, Pang HH, et al
    Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant.
    Hepatology. 2021 Jun 6. doi: 10.1002/hep.31992.
    PubMed         Abstract available

  35. YANG W, He H, Wang T, Su N, et al
    Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis.
    Hepatology. 2021 Jun 5. doi: 10.1002/hep.31987.
    PubMed         Abstract available

  36. SHAH V, Iwakiri Y, Boyer JL
    Obituary for Roberto J. Groszmann - the Father of Portal Hypertension.
    Hepatology. 2021 Jun 9. doi: 10.1002/hep.31996.
    PubMed         Abstract available

  37. SOLIPURAM V, Baretti M, Kim AY, Chen LX, et al
    Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
    Hepatology. 2021 Jun 9. doi: 10.1002/hep.31998.
    PubMed         Abstract available

  38. JAESCHKE H, Ramachandran A
    Letter to the Editor: Does c-Jun N-Terminal Kinase Regulate Acetaminophen Hepatotoxicity by Modulating Nuclear Factor Erythroid 2-Related Factor 2-Dependent Genes or Mitochondrial Oxidant Stress?
    Hepatology. 2021;73:467-468.
    PubMed        

  39. TANG X, Wang XJ
    REPLY.
    Hepatology. 2021;73:468-469.
    PubMed        

  40. CHOI J, Lim YS
    REPLY.
    Hepatology. 2021;73:467.
    PubMed        

  41. CASEY L, Aday A, Rule J, Lee WM, et al
    Letter to the Editor: Response to Letter Concerning Our Pregnancy Manuscript.
    Hepatology. 2021;73:465.
    PubMed        

  42. LEE YT, Wang JJ, Luu M, Noureddin M, et al
    Comparison of Clinical Features and Outcomes between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Hepatology. 2021 Jun 11. doi: 10.1002/hep.32007.
    PubMed         Abstract available

  43. JINDAL A, Sharma S
    Biomarkers for predicting renal outcomes in decompensated cirrhosis - Need a closer look!
    Hepatology. 2021 Jun 9. doi: 10.1002/hep.32005.
    PubMed         Abstract available


    J Gastroenterol

  44. HARADA M
    Diagnosis for Wilson disease: this disease may not be a rare disease.
    J Gastroenterol. 2021;56:114-115.
    PubMed        


    J Gastroenterol Hepatol

  45. FAJARDO J, Nunez E, Szafranska J, Poca M, et al
    We report a patient who presented intrahepatic cholangitis and cholecystitis after SARS-CoV-2 infection.
    J Gastroenterol Hepatol. 2021 Jun 9. doi: 10.1111/jgh.15537.
    PubMed        

  46. ZHOU J, Wang C, Chen Z
    Hepatobiliary and Pancreatic: Castleman disease of the pancreas diagnosed by endoscopic ultrasound.
    J Gastroenterol Hepatol. 2021 May 31. doi: 10.1111/jgh.15520.
    PubMed        

  47. KANEKO S, Kurosaki M, Inada K, Kirino S, et al
    Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2021 May 31. doi: 10.1111/jgh.15563.
    PubMed         Abstract available

  48. AGARWAL S, Sharma S, Kumar M, Venishetty S, et al
    Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: A proof of concept.
    J Gastroenterol Hepatol. 2021 May 28. doi: 10.1111/jgh.15560.
    PubMed         Abstract available


    J Hepatol

  49. BAUMERT TF
    "We can and should do better" - an interview with the 2020 Nobel prize laureates who revolutionized hepatology.
    J Hepatol. 2021 May 25. pii: S0168-8278(21)00312.
    PubMed        

  50. KUDO M, Matilla A, Santoro A, Melero I, et al
    CheckMate 040 Cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis.
    J Hepatol. 2021 May 12. pii: S0168-8278(21)00313.
    PubMed         Abstract available

  51. KOLAMUNNAGE-DONA R, Berhane S, Potts H, Williams EH, et al
    Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma.
    J Hepatol. 2021 May 27. pii: S0168-8278(21)00350.
    PubMed         Abstract available


    N Engl J Med

  52. WONG F, Curry MP, Sanyal AJ
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. Reply.
    N Engl J Med. 2021;384:e90.
    PubMed        

  53. CHINA L, Freemantle N, O'Brien A
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. Reply.
    N Engl J Med. 2021;384:e90.
    PubMed        

  54. RATHI S, Kalantri A, Kalantri S
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    PubMed        

  55. CHAUHAN A, Sharma S, Saraya A
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    PubMed        

  56. ELFEKI MA, O'Shea R, Carey WD
    Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.
    N Engl J Med. 2021;384:e90.
    PubMed        


    Oncogene

  57. SHEN M, Zhang R, Jia W, Zhu Z, et al
    Nuclear scaffold protein p54(nrb)/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01848.
    PubMed         Abstract available

  58. WANG X, Dong J, Li X, Cheng Z, et al
    CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01867.
    PubMed         Abstract available

  59. WANG S, Cao K, Liao Y, Zhang W, et al
    CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01855.
    PubMed         Abstract available


    PLoS One

  60. FATTAHI N, Rezaei N, Asadi-Lari M, Yousefi M, et al
    Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis.
    PLoS One. 2021;16:e0245468.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  61. CHIBAYA L, Karim B, Zhang H, Jones SN, et al
    Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Radiology

  62. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
    Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
    Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
    PubMed         Abstract available


    Transplant Proc

  63. DAOUD A, Soliman K, Teeter L, Ali H, et al
    Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients.
    Transplant Proc. 2021;53:833-838.
    PubMed         Abstract available


    Transplantation

  64. PERI AM, Magro B, van den Bogaart L, Dalla Pria A, et al
    Successful Treatment of Suspected Donor-derived Human Herpesvirus-8 Infection in a Liver Transplant Patient With Coronavirus Disease-19.
    Transplantation. 2021;105:e65-e67.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: